The Valley Desk

ReviewChronic respiratory diseasePublished

How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Chronic respiratory disease
Published
Subject terms
Humans; Pulmonary Disease, Chronic Obstructive; Bronchodilator Agents; Administration, Inhalation; Primary Health Care; Clinical Trials as Topic; Adrenergic beta-2 Receptor Agonists; Primary Care; Long-acting Bronchodilators; Symptomatic Chronic Obstructive Pulmonary Disease; Initial Maintenance Therapy; Long-acting Muscarinic Antagonist/long-acting Β2-agonist Dual Therapy
PubMed ID
37800633
PubMed Central ID
PMC10903204
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal